These findings suggest that GBM cells have increased dependence on DHHC9-mediated GLUT1 S-palmitoylation, unlike normal astrocytes which primarily depend on other mechanisms to maintain their glycolysis, highlighting that DHHC9 could be a potential target for cancer cell-specific inhibition of glycolysis. The gene discussed is ZDHHC9; the disease is glioblastoma.